<p>Number of patients per arm for an active controlled trial with the number of new cortical lesions counted over 1 and 2 years.</p
<p>Patients baseline characteristics and number of patients per treatment arm in phase II.</p
The number of users of examined medicines among patients with rheumatoid and seropositive arthritis ...
<p>Number of patients that can be manipulated before, on average, the manipulation is detected by th...
<p>Number of patients who had the follow up sample in each two-month period of time.</p
<p>Number and proportion of initiated, completed, and published academic drug trials by year of appr...
<p>Number of patients experiencing minor and major adverse events per study arm (related to ciclospo...
<p>Number of patients analysed and treatment outcomes at 12 months of ART by cohort on the full data...
Average number of patients allocated to control group (Arm 0) for scenarios 8 and 9 and different re...
<p>Numbers of patients in each CAP category before implantation, 6, 12, 24 months after implantation...
<p>Number of antiglaucoma medications prescribed in patients with CAS and the comparison cohort.</p
<p>Number of trials started and completed each year since launching ClinicalTrials.gov repository.</...
<p>Number of patients with different follow up periods in derivation and validation cohort.</p
<p>Number of patients enrolled to the study at the two community clinics, according to final diagnos...
<p>Number of events and incidence rates of clinical outcomes within 1 year for 2.5 mg BID apixaban a...
<p>TNF, tumor necrosis factor.</p><p>Number of patients according to the course of treatment.</p
<p>Patients baseline characteristics and number of patients per treatment arm in phase II.</p
The number of users of examined medicines among patients with rheumatoid and seropositive arthritis ...
<p>Number of patients that can be manipulated before, on average, the manipulation is detected by th...
<p>Number of patients who had the follow up sample in each two-month period of time.</p
<p>Number and proportion of initiated, completed, and published academic drug trials by year of appr...
<p>Number of patients experiencing minor and major adverse events per study arm (related to ciclospo...
<p>Number of patients analysed and treatment outcomes at 12 months of ART by cohort on the full data...
Average number of patients allocated to control group (Arm 0) for scenarios 8 and 9 and different re...
<p>Numbers of patients in each CAP category before implantation, 6, 12, 24 months after implantation...
<p>Number of antiglaucoma medications prescribed in patients with CAS and the comparison cohort.</p
<p>Number of trials started and completed each year since launching ClinicalTrials.gov repository.</...
<p>Number of patients with different follow up periods in derivation and validation cohort.</p
<p>Number of patients enrolled to the study at the two community clinics, according to final diagnos...
<p>Number of events and incidence rates of clinical outcomes within 1 year for 2.5 mg BID apixaban a...
<p>TNF, tumor necrosis factor.</p><p>Number of patients according to the course of treatment.</p
<p>Patients baseline characteristics and number of patients per treatment arm in phase II.</p
The number of users of examined medicines among patients with rheumatoid and seropositive arthritis ...
<p>Number of patients that can be manipulated before, on average, the manipulation is detected by th...
DOI
Add to ORKG